<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>70(4)</volume><submitter>Brehmer-Henkel S</submitter><funding>AQUANOVA AG</funding><pubmed_abstract>Xanthohumol is a prenylated chalcone, which is mainly found in hops. Experimental studies show a variety of cardioprotective effects for xanthohumol, but so far there are only a few controlled studies on the bioavailability and efficacy of xanthohumol in humans. In a randomized crossover bioavailability trial, the plasma kinetics of 86 mg and 172 mg each of micellar or native xanthohumol were investigated. Blood samples were obtained at fasting (t&lt;sub>0&lt;/sub>), regularly until 9 h and 24 h after oral xanthohumol bolus administration and the plasma concentrations of xanthohumol, xanthohumol glucuronide, and xanthohumol sulfate were analyzed. Micellation increased the area under the plasma concentration-time curve (AUC) (p &lt; 0.001) and maximum plasma concentration (p &lt;0.001). Both formulatio</pubmed_abstract><journal>Molecular nutrition &amp; food research</journal><pagination>e70413</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12925386</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Bioavailability of Xanthohumol in Humans and the Influence of Formulation and Dose: Randomized Controlled Trial Data.</pubmed_title><pmcid>PMC12925386</pmcid><pubmed_authors>Coenen M</pubmed_authors><pubmed_authors>Nemeth R</pubmed_authors><pubmed_authors>Maris R</pubmed_authors><pubmed_authors>Stoffel-Wagner B</pubmed_authors><pubmed_authors>Sus N</pubmed_authors><pubmed_authors>Eickeler M</pubmed_authors><pubmed_authors>Kopp C</pubmed_authors><pubmed_authors>Frank J</pubmed_authors><pubmed_authors>Brehmer-Henkel S</pubmed_authors><pubmed_authors>Diekmann C</pubmed_authors><pubmed_authors>Egert S</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Bioavailability of Xanthohumol in Humans and the Influence of Formulation and Dose: Randomized Controlled Trial Data.</name><description>Xanthohumol is a prenylated chalcone, which is mainly found in hops. Experimental studies show a variety of cardioprotective effects for xanthohumol, but so far there are only a few controlled studies on the bioavailability and efficacy of xanthohumol in humans. In a randomized crossover bioavailability trial, the plasma kinetics of 86 mg and 172 mg each of micellar or native xanthohumol were investigated. Blood samples were obtained at fasting (t&lt;sub>0&lt;/sub>), regularly until 9 h and 24 h after oral xanthohumol bolus administration and the plasma concentrations of xanthohumol, xanthohumol glucuronide, and xanthohumol sulfate were analyzed. Micellation increased the area under the plasma concentration-time curve (AUC) (p &lt; 0.001) and maximum plasma concentration (p &lt;0.001). Both formulatio</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T18:48:23.439Z</modification><creation>2026-07-12T03:08:30.736Z</creation></dates><accession>S-EPMC12925386</accession><cross_references><pubmed>41723719</pubmed><doi>10.1002/mnfr.70413</doi></cross_references></HashMap>